Open Access
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
1
2
CovalAb, Research Department, 11 Avenue Albert Einstein, 69100 Villeurbanne, Lyon, France
|
Publication type: Journal Article
Publication date: 2017-10-25
PubMed ID:
31548531
Drug Discovery
Immunology
Immunology and Allergy
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
International Journal of Molecular Sciences
2 publications, 3.08%
|
|
|
Cancers
2 publications, 3.08%
|
|
|
Cells
2 publications, 3.08%
|
|
|
Frontiers in Molecular Biosciences
2 publications, 3.08%
|
|
|
Frontiers in Immunology
2 publications, 3.08%
|
|
|
Cell Death and Disease
2 publications, 3.08%
|
|
|
Journal of Controlled Release
2 publications, 3.08%
|
|
|
Biomaterials
2 publications, 3.08%
|
|
|
Biomacromolecules
2 publications, 3.08%
|
|
|
International Journal of Biological Macromolecules
2 publications, 3.08%
|
|
|
Drugs
2 publications, 3.08%
|
|
|
Biochemistry (Moscow)
2 publications, 3.08%
|
|
|
ImmunoHorizons
1 publication, 1.54%
|
|
|
Future Oncology
1 publication, 1.54%
|
|
|
Biochemical Society Transactions
1 publication, 1.54%
|
|
|
Pharmaceutics
1 publication, 1.54%
|
|
|
Antibodies
1 publication, 1.54%
|
|
|
Biomolecules
1 publication, 1.54%
|
|
|
Molecules
1 publication, 1.54%
|
|
|
Scientific Reports
1 publication, 1.54%
|
|
|
Applied Microbiology and Biotechnology
1 publication, 1.54%
|
|
|
Nature Communications
1 publication, 1.54%
|
|
|
Journal of Experimental and Clinical Cancer Research
1 publication, 1.54%
|
|
|
International Journal of Pharmaceutics
1 publication, 1.54%
|
|
|
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.54%
|
|
|
Journal of Biological Chemistry
1 publication, 1.54%
|
|
|
Molecular Therapy - Oncolytics
1 publication, 1.54%
|
|
|
Biomedicine and Pharmacotherapy
1 publication, 1.54%
|
|
|
ChemBioChem
1 publication, 1.54%
|
|
|
1
2
|
Publishers
|
2
4
6
8
10
12
14
16
|
|
|
Elsevier
15 publications, 23.08%
|
|
|
MDPI
11 publications, 16.92%
|
|
|
Springer Nature
10 publications, 15.38%
|
|
|
Frontiers Media S.A.
5 publications, 7.69%
|
|
|
Taylor & Francis
4 publications, 6.15%
|
|
|
Wiley
3 publications, 4.62%
|
|
|
American Chemical Society (ACS)
3 publications, 4.62%
|
|
|
Pleiades Publishing
2 publications, 3.08%
|
|
|
The American Association of Immunologists
1 publication, 1.54%
|
|
|
Portland Press
1 publication, 1.54%
|
|
|
American Society for Biochemistry and Molecular Biology
1 publication, 1.54%
|
|
|
Hindawi Limited
1 publication, 1.54%
|
|
|
American Society of Hematology
1 publication, 1.54%
|
|
|
OAE Publishing Inc.
1 publication, 1.54%
|
|
|
Research Square Platform LLC
1 publication, 1.54%
|
|
|
American Society of Clinical Oncology (ASCO)
1 publication, 1.54%
|
|
|
The Russian Academy of Sciences
1 publication, 1.54%
|
|
|
Oxford University Press
1 publication, 1.54%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 publication, 1.54%
|
|
|
2
4
6
8
10
12
14
16
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
65
Total citations:
65
Citations from 2024:
19
(29%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Dubuisson A. et al. Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy // Antibodies. 2017. Vol. 6. No. 4. p. 16.
GOST all authors (up to 50)
Copy
Dubuisson A., Micheau O. Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy // Antibodies. 2017. Vol. 6. No. 4. p. 16.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3390/antib6040016
UR - https://doi.org/10.3390/antib6040016
TI - Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy
T2 - Antibodies
AU - Dubuisson, Agathe
AU - Micheau, Olivier
PY - 2017
DA - 2017/10/25
PB - MDPI
SP - 16
IS - 4
VL - 6
PMID - 31548531
SN - 2073-4468
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Dubuisson,
author = {Agathe Dubuisson and Olivier Micheau},
title = {Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy},
journal = {Antibodies},
year = {2017},
volume = {6},
publisher = {MDPI},
month = {oct},
url = {https://doi.org/10.3390/antib6040016},
number = {4},
pages = {16},
doi = {10.3390/antib6040016}
}
Cite this
MLA
Copy
Dubuisson, Agathe, et al. “Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy.” Antibodies, vol. 6, no. 4, Oct. 2017, p. 16. https://doi.org/10.3390/antib6040016.